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FEBS Open Bio is seeking to appoint its first Editor-
in-Chief. This open access journal was launched in
2011 by the Federation of European Biochemical Soci-
eties (FEBS). FEBS was very experienced in running
scientific journals – owning three renowned interna-
tional journals: The FEBS Journal, FEBS Letters and
Molecular Oncology – but this was its first open access
journal.
From the beginning, FEBS was determined to apply
the same ethical standards for peer review as for the
other journals it owned. Many of the original editorial
board were also members of the editorial boards of
The FEBS Journal, FEBS Letters and Molecular
Oncology. Where FEBS Open Bio diverges from its fel-
low journals is in the assessment of impact – FEBS
Open Bio focuses on the technical soundness of manu-
scripts, leaving the scientific community to judge the
importance of the reported research.
FEBS Open Bio received over 100 submissions in its
first year and published 63 papers. Growth has been
steady since then, with close to 2500 submissions to
date. The journal published 177 articles in 2018 and
expects to publish its 1000th paper before the end of
this year.
FEBS Open Bio was accepted for indexing in Science
Citation Index Expanded (accessed through Web of
Science) in 2014. This stamp of approval also meant
that the journal receives an Impact Factor, although
as a signatory of the San Francisco Declaration on
Research Assessment (DORA), the journal would
rather focus on the wide availability of and credit
accruing to the individual articles it publishes. There
were over 250 000 downloads of FEBS Open Bio arti-
cles in 2018, and 97% of the papers published in
2011–2016 have received at least one citation with an
average of nine citations per paper for this cohort to
August 2019. All FEBS Open Bio articles are included
in PubMed Central and thus searchable in PubMed,
but in February 2019 the journal was formally
accepted for indexing in MedLine, which means that
articles are now added to PubMed when they first
appear online.
Mary Purton was appointed Executive Editor of
FEBS Open Bio at launch and has remained at the helm
throughout. She has guided the journal through its
development, well supported by the Editors-in-Chief of
the other FEBS journals and the FEBS Open Bio edito-
rial board. The latter has been expanded as journal sub-
missions have grown. Initially, submissions were often
those originally submitted to the other FEBS Press jour-
nals and transferred to FEBS Open Bio, but direct sub-
missions accounted for around half of all submissions
by 2017 and more than two-thirds in 2019 to date. The
journal is now independent of its ‘parents’.
The FEBS publications committee have decided that
for the next phase of its development, FEBS Open Bio
would benefit from dividing the Executive Editor posi-
tion, appointing an academic Editor-in-Chief with
responsibility for expanding the editorial board and
determining the editorial strategy for the journal, and
an Editorial Manager to oversee the day-to-day run-
ning of the editorial office.
Applications are invited for the new position of Edi-
tor-in-Chief of FEBS Open Bio. The ideal candidate
will have an international reputation as an outstanding
researcher, with a demonstrated commitment to partic-
ipation in academic peer review. They will need to
have the time and commitment to meet journal dead-
lines on a regular basis, and to work diplomatically
with authors and editorial board members.
The Editor-in-Chief will act as an ambassador for
the journal, actively promoting it to the scientific com-
munity, and will set the journal’s editorial strategy, in
consultation with the editorial board. They will seek
out new members of the editorial board as required,
and be expected to uphold the ethics policies of FEBS
Press and to resolve any ethical issues that arise.
See https://febs.onlinelibrary.wiley.com/journal/22115463
for more information and details of how apply. The
closing date for applications is 23 September 2019.
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